Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness
Status:
Unknown status
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
The Purpose of this study is to predict antidepressant response in advance using
pharmacogenomics and peripheral biological markers in depressed patients.